|
Mechanismalbumin agonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure.
The goal of this phase 2, multicenter, randomized, controlled study is to evaluate the effect of albumin treatment on B cell and other immune cell gene exptression in adults with septic shock.
100 Clinical Results associated with Albimmune SL
0 Patents (Medical) associated with Albimmune SL
100 Deals associated with Albimmune SL
100 Translational Medicine associated with Albimmune SL